MELBOURNE, Australia & ST. GALLEN, Switzerland–(BUSINESS WIRE)–Regulatory News: AD HOC ANNOUNCEMENT PURSUANT TO ART. 53 LR CSL Limited (ASX: CSL; USOTC:CSLLY) today announced an update regarding the Vifor Pharma AG acquisition. On January 18, 2022, CSL Behring AG (the Offeror) published the offer prospectus (the Offer Prospectus) for its public tender offer according to … [Read more…]
– Introducing digital transformation (DX) for monitoring work and reducing new drug development costs – TOKYO–(BUSINESS WIRE)–Aculys Pharma, Inc. (“Aculys Pharma” Headquarters: Minato-ku, Tokyo, President and CEO: Kazunari Tsunaba), a company focused on the development and commercialization of new innovative drugs in the fields of neurology and psychiatry, has entered into a contract with SUSMED, … [Read more…]
SHORT HILLS, N.J.–(BUSINESS WIRE)–Humanigen, Inc. (Nasdaq: HGEN) (“Humanigen”) has been informed of preliminary topline results from the National Institute of Allergy and Infectious Diseases’ (NIAID) ACTIV-5/BET-B trial evaluating lenzilumab plus remdesivir versus placebo plus remdesivir in hospitalized COVID-19 patients. The trial did not achieve statistical significance on the primary endpoint, which was defined as the … [Read more…]
BOSTON–(BUSINESS WIRE)–#biotech–ByteDance has pitched into life sciences. Last October, this internet tech giant invested in the biotech startup Shuimu BioSciences (Shuimu), a company leveraging the power of cryogenic electron microscopy (cryo-EM) and AI to revolutionize drug discovery. Since the outbreak of the coronavirus, life sciences has become one of the most promising sectors to venture … [Read more…]
LOS ANGELES–(BUSINESS WIRE)–Ashish Buttan, BDS, MBA, has been promoted to Vice President, Physician Partnerships at Children’s Hospital Los Angeles (CHLA). This new role expands his existing responsibilities as Executive Director of the Neurological Institute and the Behavioral Health Institute to include physician alignment, stewardship and performance management with CHLA’s five academic departments and the Children’s … [Read more…]
LOS ANGELES–(BUSINESS WIRE)–Today the Los Angeles County Board of Supervisors approved a motion by Supervisor and Chair of the Board Holly Mitchell, which will help focus County resources on growing LA’s life sciences industry. As the fastest growing segment of Los Angeles’ economy, LA County’s life sciences sector employs nearly 100,000 people and is home … [Read more…]
Hartsville hospital recognized for achievements in patient and family engagement, quality care and patient safety HARTSVILLE, Tenn.–(BUSINESS WIRE)–Trousdale Medical Center (TMC), a member of HighPoint Health System, today announced that it has been named a LifePoint Health National Quality Leader. This designation recognizes hospitals within the LifePoint Health system that have enrolled in the LifePoint … [Read more…]
ESMO Immuno-Oncology and Technology Article Details Importance of Intracellular Delivery to Drive Effective MHC-I Mediated Activation of CD8 T Cells Paper Highlights Preclinical SQZ® APC Combination Data with PD-1 IL2v and Manufacturing Benefits of the Cell Squeeze® Technology WATERTOWN, Mass.–(BUSINESS WIRE)–SQZ Biotechnologies Company (NYSE: SQZ), focused on unlocking the full potential of cell therapies for … [Read more…]
NEWPORT BEACH, Calif.–(BUSINESS WIRE)–Pacific Life has expanded its offering of life insurance coverage to eligible individuals living with human immunodeficiency virus (HIV). “In keeping with our progressive approach to underwriting, we are leveraging the latest medical advancements in therapeutics for HIV in order to offer coverage to individuals living with this chronic condition,” said Dawn … [Read more…]
Independent Data and Safety Monitoring Committee Recommends Continuing Study Without Sample Size Adjustment IDSMC Did Not Identify Any Safety Concerns Phase 2 Study Target Enrollment Achieved; Final Data and Communication Expected in October 2023 Conference Call and Webcast Today at 2:00 p.m. PDT/5:00 p.m. EDT SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Atara Biotherapeutics, Inc. (Nasdaq: ATRA), … [Read more…]
